ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain
- 1 August 1998
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 801 (1-2) , 158-163
- https://doi.org/10.1016/s0006-8993(98)00596-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of the Nucleus Raphe Magnus in Antinociception Produced by ABT-594: Immediate Early Gene Responses Possibly Linked to Neuronal Nicotinic Acetylcholine Receptors on Serotonergic NeuronsJournal of Neuroscience, 1998
- Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in miceEuropean Journal of Pharmacology, 1998
- Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine ReceptorsScience, 1998
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesicsPain, 1994
- Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic painPain, 1993
- Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidencePain, 1993
- Central nervous system plasticity in the tonic pain response to subcutaneous formalin injectionBrain Research, 1990
- Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent inputNature, 1987
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980